Estrogen and Progesterone Receptors, C-ERBB-2, p53, and BCL-2 in Thirty-three Invasive Micropapillary Breast Carcinomas
- 31 December 1996
- journal article
- Published by Elsevier BV in Pathology - Research and Practice
- Vol. 192 (1), 27-32
- https://doi.org/10.1016/s0344-0338(96)80126-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocolCancer, 1994
- Invasive micropapillary carcinoma of the breast: A new special type of invasive mammary carcinomaPathology - Research and Practice, 1994
- The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- Prognostic factors in early breast carcinomaCancer, 1994
- c-erbB-2 Amplification and overexpression in breast cancer: evaluation and comparison of southern BLOT, SLOT BLOT, ELISA and immunohistochemistryPathology, 1993
- A simplified histoscore for the estrogen receptor assay in breast cancerPathology - Research and Practice, 1992
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI Journal of the National Cancer Institute, 1992
- Histological Assessment of the Prognostic Factors in Female Breast CancerOncology, 1992
- p53 alterations in all stages of breast cancerJournal of Surgical Oncology, 1991
- Prognosis and Breast CancerThe American Journal of Surgical Pathology, 1991